Skip to content
Screener

Enpro NPO Food and pharmaceutical — Total third-party sales

Other product segments

Semiconductors
$97M+15.9%
General industrial
$85.9M+16.7%
Food and biopharmaceutical
$76.3M
Commercial vehicle
$37M-8.0%
Aerospace
$22.5M-7.8%
Power generation
$20.4M+17.2%
Oil and gas
$17.8M+11.9%

Similar metrics at other companies

AVT
AVTRThird-party — Net Sales
$811.9M+2.8%
First Watch Restaurant Group, Inc. logo
FWRGThird-party delivery sales — Total revenues
$39.69M+24.0%
HES
HESMThird Party Services — Revenue (Gross)
$17.9M+118%
Lands' End, Inc. logo
LEThird Party — Revenue
$13.29M-5.6%
Amazon logo
AMZNThird-party seller services — Net Sales
$46.78B+15.9%
OPA
OPALThird party station service and maintenance — Total revenues
-$270K-104%

Other financials

Income statement

See full
Revenue$303.0M+10.9%
Gross profit$130.0M+10.0%
Operating income$43.5M+4.1%
Net income$27.4M+11.8%
EPS (diluted)$1.29+12.2%

Balance sheet

See full
Cash & equivalents$79.2M-67.0%
Total debt$617.8M-4.5%
Total equity$1.6B+6.9%
Total assets$2.6B+5.1%

Cash flow

See full
Operating cash flow$39.6M+88.6%
CapEx$12.2M+52.5%
Free cash flow$27.4M+111%

Valuation

See full
Market cap$6.95B+50.8%
Enterprise value$7.49B+50.4%
P/E69.6×
P/S5.9×+1.7×

Profitability

See full
Gross margin42.6%-0.4pp
Operating margin13.9%-0.7pp
Net margin7.8%
FCF margin14.8%+0.8pp

Returns & leverage

See full
Return on equity5.8%
Debt / equity0.4×0.0×
Current ratio2.2×-0.7×

Where this comes from

Reported directly by Enpro in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The source filing: Enpro’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 12:38 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-030295
(in millions)Sealing TechnologiesAdvanced Surface TechnologiesTotal
Aerospace$20.4$2.1$22.5
Commercial vehicle37.037.0
Food and pharmaceutical22.422.4
General industrial79.36.685.9
Oil and gas16.31.517.8
Power generation20.420.4
Semiconductors3.293.897.0
Total third-party sales$199.0$104.0$303.0

Item 1. Financial Statements

FAQ

What is Enpro's food and pharmaceutical — total third-party sales?
Enpro (NPO) reported food and pharmaceutical — total third-party sales of $22.4M in Q1 2026.
How has Enpro's food and pharmaceutical — total third-party sales changed year-over-year?
Enpro's food and pharmaceutical — total third-party sales increased by 24.4% year-over-year, from $18M to $22.4M.
What is the long-term trend for Enpro's food and pharmaceutical — total third-party sales?
Over 3 years (2021 to 2024), Enpro's food and pharmaceutical — total third-party sales has grown at a 0.9% compound annual growth rate (CAGR), from $65.9M to $67.7M.
What does food and pharmaceutical — total third-party sales mean?
This metric represents the total revenue generated from external customers specifically attributable to the food and pharmaceutical product segment. It reflects the market demand for specialized industrial components and sealing solutions tailored to the stringent regulatory and hygiene requirements of the food processing and pharmaceutical manufacturing industries. Tracking this figure allows stakeholders to assess the segment's competitive positioning and growth trajectory within these specific end-markets.

Ask your AI about Enpro's food and pharmaceutical — total third-party sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude